title: [Time interval between ovarian cancer surgery and chemotherapy--secondary publication?].
abstract: Worldwide, much effort goes into performing optimal surgery in treatment of epithelial ovarian cancer (EOC). However, the optimal timing (TI) of postoperative chemotherapy for ovarian cancer remains poorly defined. The relevant literature comprises seven studies with varying characteristics and includes different prognostic factors. The general supposition is that the time interval does not have a prognostic influence, but experimental studies have shown that it does affect cancer prognosis.
authors.affiliation: Arhus Universitetshospital, Gynaekologisk Obstetrisk Afdeling, Denmark.
authors.forename: Erling Peter
authors.initials: EP
authors.lastname: Larsen
authors.forename: Jan
authors.initials: J
authors.lastname: Blaakaer
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use; D017024:Chemotherapy, Adjuvant; D005260:Female; D006801:Humans; D009375:Neoplasms, Glandular and Epithelial / Q000188:drug therapy / Q000401:mortality / Q000601:surgery*; D010051:Ovarian Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000601:surgery*; D011379:Prognosis; D015996:Survival Rate; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents